Found 544 hits.
| 41. | Maurer, M., Altrichter, S., Ardelean, E., Krause, K., Magerl, M., Metz, M., Siebenhaar, F., Weller, K., and Zuberbier, T.: Therapeutic alternatives for antihistamine-refractory urticaria. Hautarzt 2010: 61; 765-769. IF: 0.45 |
| 270 | Cherrez, A., Maurer, M. Weller, K., Calderon, J. C., Simancas-Racines, D., and Cherrez-Ojeda, I.+: Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador. World Allergy Organ. J. 2017: 10; 21. IF: 5.68 |
o.270
| 29 | Peters, E. M., Tobin, D. J., Botchkareva, N., Maurer, M. and Paus, R.+: Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J. Histochem. Cytochem. 2002: 50; 751-766. IF: 1.15 |
o.029
| 60. | Magerl, M., Brasch, J., Förster, U., Hauswald, B., Mohr, B., Präßler, J., Treudler, R., Vetter, R., Wahn, V., Zampelli, V., Ziemer, M., and Maurer, M.: Diagnostik und Ausschluss des hereditären Angioödems – Ein standardisierter Ansatz für die Praxis. Hautarzt 2012: 63; 567-572. IF: 0.50 |
| 50 | Siebenhaar, F., Sharov, A. A., Peters, E. M. J., Sharova, T. Y., Syska, W., Mardaryev, A. N., Freyschmidt-Paul, P., Sundberg, J. P., Maurer, M. and Botchkarev, V. A.+: Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata). J. Invest. Dermatol. 2007: 127; 1489-1497. IF: 4.83 |
| 7. | Siebenhaar, F. and Maurer, M.: Mastozytose. In: Schöfer, H. and Baur-Beger, S., editors: Derma-Net-Online: Aktuelle Dermatologie für Dermatologen und dermatologisch Interessierte (www.derma-net-online.de), 2007 |
bc.07
| 308 | Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. World Allergy Organ. J. 2018: 11; 5. IF: 3.68 |
o.308
| 309 | Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. Allergy 2018: 73; 1575-1596. IF: 6.77 |
| 189 | Prepageran, N.+, Wang, D. Y., Nair, G., and Maurer, M.: The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective. Asia Pac. Allergy 2014: 4; 142-148. IF: N/A |